@showlow_wadlow @kevinnbass THEY WERENT DYING BECAUSE THEY DIDNT HAVE COVID YET. EVERYPLACE COVID WENT, SUSCEPTIBLE PATIENTS DIED, WITH OR WITHOUT INTUBATION China didn’t intubate many people with Covid because they didn’t have as many ventilators. THEY S
@_LoveMTB_ @Carl31508201 @cogno @skabowl The rest is purely conjecture? You don’t know, do you? https://t.co/QuOFo7BqJD
RT @silverhalo_1: $IHL "....the mortality rate in COVID-19-associated ARDS is 45%, and the incidence of ARDS among non-survivors of COVID-1…
RT @silverhalo_1: $IHL "....the mortality rate in COVID-19-associated ARDS is 45%, and the incidence of ARDS among non-survivors of COVID-1…
$IHL "....the mortality rate in COVID-19-associated ARDS is 45%, and the incidence of ARDS among non-survivors of COVID-19 is 90%." 🚑🚑 #ARDS is the biggest killer in COVID patients - IHL seeking approval for use of IHL-675A - SAVE LIVES #FDA https://t.co/
@ArthurHayle69 "Among hospitalized COVID-19 patients, approximately 1/3 (33%) develop ARDS, 1/4 (26%) require transfer to an ICU, 1/6 (16%) receive IMV, and 1/6 (16%) die" (source: https://t.co/HZx3UpGE1A. 60% of ppl being symptomatic = covid is serious, w
RT @Altgov_sewPPE: #ARDS #AccuteRespiratoryDistressSyndrome “...studies for which data is available indicate that among hospitalized COVID…
#ARDS #AccuteRespiratoryDistressSyndrome “...studies for which data is available indicate that among hospitalized COVID-19 patients, approximately 1/3 (33%) develop ARDS, 1/4 (26%) require transfer to an ICU, 1/6 (16%) receive IMV, and 1/6 (16%) die...” h
RT @solnatide: Coordinator #Apeptico shares a #publication👇 “Incidence of #ARDS and outcomes in hospitalized patients with #COVID-19: a glo…
RT @solnatide: Coordinator #Apeptico shares a #publication👇 “Incidence of #ARDS and outcomes in hospitalized patients with #COVID-19: a glo…
RT @solnatide: Coordinator #Apeptico shares a #publication👇 “Incidence of #ARDS and outcomes in hospitalized patients with #COVID-19: a glo…
RT @solnatide: Coordinator #Apeptico shares a #publication👇 “Incidence of #ARDS and outcomes in hospitalized patients with #COVID-19: a glo…
Coordinator #Apeptico shares a #publication👇 “Incidence of #ARDS and outcomes in hospitalized patients with #COVID-19: a global literature survey”. Take a look @coronadxeu @TheCovidX @Covirna_EU @COVINFORM_EU @covid_x @PER1SCOPE_EU @porsav2020 @inno4cov19
Incidencia de SDRA por #COVID19 y evolución en pacientes hospitalizados. https://t.co/pb6iuVnNWZ https://t.co/VYdGDge1Yi
.@BlackVoices4DJT
RT @LarryBoorstein: @EricTopol @realDonaldTrump President Trump may want to check: 33% of hospitalized patients develop ARDS - acute respir…
RT @LarryBoorstein: President Trump may want to check: 33% of hospitalized patients develop ARDS - acute respiratory distress syndrome; 26%…
RT @LarryBoorstein: @EricTopol @realDonaldTrump President Trump may want to check: 33% of hospitalized patients develop ARDS - acute respir…
President Trump may want to check: 33% of hospitalized patients develop ARDS - acute respiratory distress syndrome; 26% require transfer to ICU; 16% receive IMV - intermittent mandatory ventilation; and 16% die. https://t.co/XckNA4tQ0b
@EricTopol @realDonaldTrump President Trump may want to check: 33% of hospitalized patients develop ARDS - acute respiratory distress syndrome; 26% require transfer to ICU; 16% receive IMV - intermittent mandatory ventilation; and 16% die. https://t.co/Xck
Incidence of #ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey @Crit_Care | #ECM https://t.co/6cHMh0BbP3
Incidence of #ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey @Crit_Care | #ECM https://t.co/c3qhhszfV5
Just published our article "Incidence of ARDS and outcomes in hospitalized .." with #BMC https://t.co/baajZc53c0
NEW PUBLICATION! Our scientific coordinator #APEPTICO recently published a #global #study in the Critical Care Journal on #ARDS and #COVID19 (https://t.co/mKAuai8Fcu). Congrats to @SusanTzotzos and colleagues! https://t.co/9syXK9jVrR
Of hospitalized #COVID19 patients: 33% develop #ARDS 26% require #ICU 16% receive IMV 16% die Of #ICU #COVID19 patients: 40% die 63% receive IMV (59% die) 75% have ARDS https://t.co/Ob6aHEUxQv https://t.co/FeybeDWo22
Incidence of #ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey @Crit_Care | #ECM https://t.co/6cHMh0BbP3
Incidence of #ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey @Crit_Care | #ECM https://t.co/c3qhhszfV5